Search clinical trials for: ocriplasmin

Total 16 results

ThromboGenics

Completed

Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies

Symptomatic Vitreomacular Adhesion

United States, Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Phase I RVC With Ocriplasmin for CRVO (RVC_CRVO)

Central Retinal Vein Occlusion

Belgium
ThromboGenics

Completed

Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS)

Vitreomacular Adhesion Including Macular Hole

United States
ThromboGenics

Completed

Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion (MIVI-5)

Exudative Age-Related Macular Degeneration | Focal Vitreomacular Adhesion

United States, United Kingdom, Germany, France, Belgium, Italy
ThromboGenics

Completed

A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

Vitrectomy

United States
Alcon Research

Completed

A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion

Symptomatic Vitreomacular Adhesion

Japan
ThromboGenics

Terminated

A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR (CIRCLE)

Disease Progression | Diabetic Retinopathy | Posterior Vitreous Detachment

United States, Czechia, United Kingdom, France, Germany, Hungary, Spain, Israel, Italy
ThromboGenics

Completed

Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy (MIC)

Vitrectomy

United States
Alcon Research

Completed

Assessment of Patients Treated With JETREA® for Vitreomacular Traction

Vitreomacular Traction | Vitreomacular Adhesion
Alcon Research

Completed

Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion

Vitreomacular Traction | Vitreomacular Adhesion

Australia
ThromboGenics

Completed

Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.

Vitreomacular Adhesion

United States
ThromboGenics

Completed

Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.

Vitreomacular Adhesion

United States, Spain, United Kingdom, Germany, Belgium, Czech Republic, Poland
ThromboGenics

Completed

The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV) (MIVI-10)

Vitrectomy

Belgium
ThromboGenics

Completed

A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) (MIVI-II)

Diabetic Macular Edema

Spain, Belgium, United Kingdom, Italy, Netherlands, Germany
ThromboGenics

Completed

A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)

Vitreomacular Traction

Belgium, Germany
The University of Texas Medical Branch, Galveston
National Institute of General Medical Sciences (NIGMS)

Completed

Assessment of Mechanisms of Improved Wound Healing

Burns

United States

3

Subscribe